Quadrature Capital’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Quadrature Capital's CRDF Position: Q2 2026 in Review
Quadrature Capital opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 26,867 shares worth $34.9K. The stake represents ﹤0.01% of the portfolio and ranks #1524 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in CRDF as recently as Q3 2025.
Quadrature Capital first reported a position in CRDF in Q2 2025 and has held it in 3 quarters since. The position peaked at $72.9K in Q2 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Quadrature Capital held 26,867 shares of Cardiff Oncology worth $34.9K as of Q2 2026.
- Cardiff Oncology was a new Quadrature Capital position in Q2 2026.
- Cardiff Oncology made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1524 holding.
- Quadrature Capital first reported a position in Cardiff Oncology in Q2 2025 and has held it in 3 quarters since.
- Quadrature Capital's Cardiff Oncology position peaked at $72.9K in Q2 2025.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.